TAUNS LABORATORIES,INC. TAUNS Laboratories,Inc. Share Price
Equities
197A
JP3452250008
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 413 JPY | +0.73% |
|
-0.96% | 0.00% |
| Sales 2024 * | 17.68B 110M 8.58B | Sales 2025 * | 18.99B 118M 9.22B | Capitalization | 41.3B 257M 20.06B |
|---|---|---|---|---|---|
| Net income 2024 * | 5.52B 34.35M 2.68B | Net income 2025 * | 5.99B 37.26M 2.91B | EV / Sales 2024 * | 2.33 x |
| Net cash position 2024 * | 154M 955K 74.59M | Net Debt 2025 * | 3.76B 23.35M 1.82B | EV / Sales 2025 * | 2.37 x |
| P/E ratio 2024 * |
7.48
x | P/E ratio 2025 * |
6.89
x | Employees | 218 |
| Yield 2024 * |
4.09% | Yield 2025 * |
6.42% | Free-Float | 25.73% |
More Fundamentals
* Assessed data
| 1 day | +0.73% | ||
| 1 week | -0.96% | ||
| Current month | +0.73% |
1 week
406.00
417.00
1 month
405.00459.00
Current year
405.00459.00
1 year
405.00459.00
3 years
405.00459.00
5 years
405.00459.00
10 years
405.00459.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/24 | 413 | +0.73% | 553,000 |
| 05/07/24 | 410 | 0.00% | 362,700 |
| 04/07/24 | 410 | 0.00% | 663,500 |
| 03/07/24 | 410 | 0.00% | 452,800 |
| 02/07/24 | 410 | -1.68% | 463,100 |
Delayed Quote Japan Exchange, July 08, 2024 at 07:00 am
More quotes
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Companyâs main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
413
JPY
Average target price
460
JPY
Spread / Average Target
+11.38%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 255M | |
| -8.55% | 12.02B | |
| -22.07% | 6.81B | |
| +27.13% | 5.47B | |
| -24.14% | 3.59B | |
| +4.11% | 2.56B | |
| +31.97% | 2.25B | |
| -67.03% | 2.24B | |
| -12.07% | 2.21B | |
| -17.96% | 1.52B |
- Stock Market
- Equities
- 197A Stock
